Citation Impact
Citing Papers
Hypomethylation of the Treg-Specific Demethylated Region in FOXP3 Is a Hallmark of the Regulatory T-cell Subtype in Adult T-cell Leukemia
2016 StandoutNobel
Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America
2010 Standout
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
Screening, prevention and treatment of viral hepatitis B reactivation in patients with haematological malignancies
2007
Active Efflux of CPT-11 and Its Metabolites in Human KB-Derived Cell Lines
1999
Etoposide: four decades of development of a topoisomerase II inhibitor
1998 Standout
The combination of radiotherapy, adjuvant chemotherapy (cyclophosphamide-doxorubicin-ftorafur) and tamoxifen in stage II breast cancer. Long-term follow-up results of a randomised trial
1992
Establishing the Diagnosis of Lung Cancer
2013 Standout
Self-Assembling Drugs: A New Approach to Biochemical Modulation in Cancer Chemotherapy
1994
Diagnostic criteria and classification of clinical subtypes of adult T‐cell leukaemia‐lymphoma
1991 Standout
Performance Characteristics of Different Modalities for Diagnosis of Suspected Lung Cancer*
2003
Suitability of Thoracic Cytology for New Therapeutic Paradigms in Non-small Cell Lung Carcinoma: High Accuracy of Tumor Subtyping and Feasibility of EGFR and KRAS Molecular Testing
2011
Mitoxantrone
1991
Cisplatin: mode of cytotoxic action and molecular basis of resistance
2003 Standout
Dynamic Covalent Chemistry
2002 StandoutNobel
Cisplatin, ifosfamide and vindesine in the chemotherapy of non-small-cell lung cancer: a combination phase II study
1990 StandoutNobel
Pulmonary Cryptococcosis in the Immunocompetent Host
2000
Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2016 Standout
Primary prophylaxis with lamivudine of hepatitis B virus reactivation in chronic HbsAg carriers with lymphoid malignancies treated with chemotherapy
2001
The cellular and molecular basis of hyperthermia
2002 Standout
Lyso-thermosensitive liposomal doxorubicin: a novel approach to enhance efficacy of thermal ablation of liver cancer
2009
Lung Cancer: Epidemiology, Etiology, and Prevention
2011 Standout
Hepatitis B virus infection
2009 Standout
Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer
2004 Standout
WHO-EORTC classification for cutaneous lymphomas
2005 Standout
The Hallmarks of Cancer
2000 Standout
The neural cell adhesion molecule NCAM in multiple myeloma
1996
Comparison of the Sensitivity of Sputum and Brush Cytology in the Diagnosis of Lung Carcinomas
1997
Virus associated malignancies: The role of viral hepatitis in hepatocellular carcinoma
2014 StandoutNobel
Preparation and cytotoxic activity of poly(ethylene glycol)-modified poly(amidoamine) dendrimers bearing adriamycin
2008
Prognostic Factors in Advanced Non-small Cell Lung Cancer: Elevated Serum Levels of Neuron Specific Enolase Indicate Poor Prognosis
2000
Targeting multidrug resistance in cancer
2006 Standout
Hepatitis B reactivation after chemotherapy: two decades of clinical research
2008
Frequency of hepatitis B virus reactivation in cancer patients undergoing cytotoxic chemotherapy: A prospective study of 626 patients with identification of risk factors
2000
2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours
2010 Standout
Chronic hepatitis B
2007 Standout
Comprehensive analysis of risk factors associating with Hepatitis B virus (HBV) reactivation in cancer patients undergoing cytotoxic chemotherapy
2004
Chronic hepatitis B: Update 2009 #
2009 Standout
Modulation of cytotoxicity of chemotherapeutic drugs by activated H-γas
1997
Lymphoproliferative Disease and Hepatitis B Reactivation: Challenges in the Era of Rapidly Evolving Targeted Therapy
2015
Chemistry in living systems
2005 StandoutNobel
Sarcoidosis
1997 Standout
Postoperative Radiotherapy in High-Risk Premenopausal Women with Breast Cancer Who Receive Adjuvant Chemotherapy
1997 Standout
Moyamoya disease: current concepts and future perspectives
2008 Standout
Hepatitis B reactivation in patients with hepatocellular carcinoma undergoing systemic chemotherapy
2004
The relationship between Moyamoya disease and bacterial infection
1997
Down's syndrome
2003 Standout
Liposomes as nanomedical devices
2015 Standout
Herb-Drug Interactions
2005 Standout
CHOP is superior to CNOP in elderly patients with aggressive lymphoma while outcome is unaffected by filgrastim treatment: results of a Nordic Lymphoma Group randomized trial
2003
Idarubicin
1991
The relationship of FOXP3 expression and clinicopathological characteristics in adult T-cell leukemia/lymphoma
2008
Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2018 Standout
Diagnostic value of bronchoalveolar lavage and postbronchoscopic sputum cytology in peripheral lung cancer
1998
Pretreatment serum albumin as a predictor of cancer survival: A systematic review of the epidemiological literature
2010 Standout
Alveolar macrophages from patients with beryllium disease and sarcoidosis express increased levels of mRNA for tumor necrosis factor-alpha and interleukin-6 but not interleukin-1 beta.
1994
Decreased sensitivity of carcinoembryonic antigen cDNA-transfected cells to adriamycin
1997
Evidence for a functional defect in the translocation of the methotrexate transport carrier in a methotrexate-resistant murine L1210 leukemia cell line.
1988
Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelines
2008 Standout
Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview
2012 Standout
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
2017 Standout
Multi‐step Carcinogenesis Model for Adult T‐cell Leukemia
1989
Hyperthermia and Drugs
1987
Isolation of a gene encoding a human reduced folate carrier (RFC1) and analysis of its expression in transport-deficient, methotrexate-resistant human breast cancer cells.
1995
Cancer/testis antigens are novel targets of immunotherapy for adult T-cell leukemia/lymphoma
2012 StandoutNobel
Ifosfamide, cisplatin, vinblastine combination chemotherapy in the treatment of advanced non-small-cell lung cancer
1990
Natural history of hepatocellular carcinoma and prognosis in relation to treatment study of 850 patients
1985 Standout
Value of bone scanning in neoplastic disease
1984
Identification of a membrane-associated folate-binding protein in human leukemic CCRF-CEM cells with transport-related methotrexate resistance.
1989
Clinical studies on cell-mediated immunity in patients with malignant disease I. Effect of immunotherapy with OK-432 on lymphocyte subpopulation and phytomitogen responsivenessin vitro
1980
Dynamic Combinatorial Chemistry
2006 Standout
Generation of Candidate Ligands for Nicotinic Acetylcholine Receptors via in situ Click Chemistry with a Soluble Acetylcholine Binding Protein Template
2012 StandoutNobel
Establishment and Expression Profiling of New Lung Cancer Cell Lines from Chinese Smokers and Lifetime Never-Smokers
2006
Insertion of an intracisternal A particle within the 5'-regulatory region of a gene encoding folate-binding protein in L1210 leukemia cells in response to low folate selection. Association with increased protein expression.
1992 StandoutNobel
Diagnosis, prevention and management of hepatitis B virus reactivation during anticancer therapy
2006
Accuracy of cytologic diagnosis and cytotyping of sputum in primary lung cancer: Analysis of 161 cases
1989
Sputum cytology by the saccomanno method in diagnosing lung malignancy
1985
A prospective study on chemotherapy-induced hepatitis B virus reactivation in chronic HBs Ag carriers with hematologic malignancies and pre-emptive therapy with nucleoside analogues
2006
Clinical value of immunotherapy for lung cancer by the streptococcal preparation OK-432
1984
Methotrexate cross-resistance in a mitoxantrone-selected multidrug-resistant MCF7 breast cancer cell line is attributable to enhanced energy-dependent drug efflux.
2000
A multidrug resistance transporter from human MCF-7 breast cancer cells
1998 Standout
Dendrimers Designed for Functions: From Physical, Photophysical, and Supramolecular Properties to Applications in Sensing, Catalysis, Molecular Electronics, Photonics, and Nanomedicine
2010 Standout
The clinical course of bone metastases from breast cancer
1987 Standout
Why, When, and How to Prevent Hepatitis B Virus Reactivation in Cancer Patients Undergoing Chemotherapy
2011
Anthraquinones As Pharmacological Tools and Drugs
2016 Standout
Engineering Chemical Reactivity on Cell Surfaces Through Oligosaccharide Biosynthesis
1997 StandoutScienceNobel
Steroid–Free Chemotherapy Decreases Risk of Hepatitis B Virus (Hbv) Reactivation in Hbv–Carriers With Lymphoma
2003
Dynamische kovalente Chemie
2002 StandoutNobel
Characterization of two cDNAs encoding folate-binding proteins from L1210 murine leukemia cells. Increased expression associated with a genomic rearrangement.
1991 StandoutNobel
Works of T Ohnoshi being referenced
Establishment of an adriamycin-resistant subline of human small cell lung cancer showing multifactorial mechanisms of resistance.
1993
Placebo-controlled double-blind comparative study on the preventive efficacy of mesna against ifosfamide-induced urinary disorders
1991
Spontaneous, complete remission in adult T-cell leukemia: a case report.
1983
Hepatitis B virus carriers in the treatment of malignant lymphoma: An epidemiological study in Japan
1997
Evolution of methotrexate resistance of human acute lymphoblastic leukemia cells in vitro.
1985
[The response of alveolar lymphocytes induced by Propionibacterium acnes in pulmonary sarcoidosis: correlation with clinical studies, pulmonary function studies and bronchoalveolar lavage].
1989
Immunochemotherapy in human lung cancer using the streptococcal agent OK-432
1976
Immunohistochemical detection of P-glycoprotein and carcinoembryonic antigen in small cell lung cancer: with reference to predictability of response to chemotherapy.
1993
[Mitoxantrone-containing combination chemotherapy in patients with non-Hodgkin's lymphoma].
1986
Cytologic and histologic correlation in primary lung cancer. A study of 154 cases with resectable tumors.
1985
Randomized Trial Comparing Chemotherapy Alone and Chemotherapy Plus Chest Irradiation in Limited Stage Small Cell Lung Cancer: A Preliminary Report
1986
Combined Cytotoxicity Effect of Hyperthermia and Anthracycline Antibiotics on Human Tumor Cells<xref ref-type="fn" rid="FN2">2</xref>
1985
Establishment of a 7-ethyl-10-hydroxy-camptothecin-resistant small cell lung cancer cell line.
2005
[Chemotherapy of aggressive non-Hodgkin's lymphomas: a retrospective analysis of a single institution].
1989
[Release of interleukin-6 by alveolar macrophages in patients with sarcoidosis].
1992
Chromosome aberrations and clinical features of adult T cell leukemia- lymphoma not associated with human T cell leukemia virus type I
1987
[Intraarterial Adriamycin for patients with hepatocellular carcinoma and metastatic liver carcinoma].
1984
Neural cell adhesion molecule expression and clinical features in small cell lung cancer: a semi-quantitative immunohistochemical approach using an immunogold-silver staining method.
1993
[Phase II study of a three-drug combination of ifosfamide, cisplatin and vindesine in non-small-cell lung cancer].
1988
Salvage chemotherapy for non-Hodgkin's lymphoma with a combination of mitoxantrone, etoposide, cisplatin, and prednisolone.
1987
Bone marrow examination for detection of metastasis in patients with bronchogenic carcinoma: an evaluation of 107 patients.
1982
Phase II study of ifosfamide, cisplatin, and vindesine combination in advanced non-small cell lung cancer.
1991
Establishment and characterization of an etoposide-resistant human small cell lung cancer cell line.
1992
[A comparative study of mitoxantrone and adriamycin in patients with non-Hodgkin's lymphoma: a preliminary result].
1986
[Serum neuron specific enolase (NSE) levels in patients with non small cell lung cancer].
1992
[Six cases of primary pulmonary cryptococcosis].
1992
[Phase II trial of mitoxantrone in patients with relapsed and refractory acute leukemia].
1985